Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Who should not have G-Shot treatment and contraindications?
Knowing when not to proceed is just as important as knowing what the G-Shot involves. A responsible page should make pause points clear and non-alarming.
Direct answer
The G-Shot should usually be avoided or postponed if you are pregnant or breastfeeding, have an active vaginal, vulval or urinary infection, unexplained bleeding, severe pelvic pain, active vulval pain, poor wound healing risk, relevant allergy or unrealistic expectations. It may also be inappropriate if symptoms suggest another condition that needs diagnosis first. A consultation should confirm whether treatment is safe to discuss at all.
A careful consultation helps separate marketing language from the clinical question: what is being treated, why this option is being considered, what alternatives exist, and what risks or limitations apply.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the key points to understand before considering contraindications.
At a glance
Contraindications
What it is
A temporary internal filler procedure, usually using hyaluronic acid in the anterior vaginal wall.
Do not proceed
Avoid or postpone for pregnancy, breastfeeding, active infection or unexplained bleeding.
Evidence status
High-quality evidence is limited, so claims should stay cautious and consent-led.
Pause point
Severe pelvic pain, urinary symptoms or unrealistic expectations need review.
Important suitability note
Active infection, unexplained bleeding, pregnancy, breastfeeding, severe pain or urinary difficulty should be assessed before treatment.
Pregnancy
Infection
Bleeding
Consent
Detailed answer
When treatment should be delayed or avoided
Contraindications protect patients from having an elective intimate procedure when assessment or treatment of another issue should come first.
Clinical context
The safest message is not “everyone can try it”; it is “some people should pause, seek review or choose a different pathway.”
Evidence
Consent
Alternatives
Infection or bleeding
Active infection, unusual discharge or unexplained bleeding should be assessed before any injection.
Pregnancy and breastfeeding
Most competitor and clinical discussions treat pregnancy and breastfeeding as reasons not to proceed.
Pain conditions
Vulvodynia, vaginismus, severe pelvic pain or dyspareunia need careful assessment and may be worsened by procedures.
Consent concerns
Pressure, unrealistic promises or inability to understand risks should stop treatment from going ahead.
What this means in practice
The G-Shot is best discussed as a temporary, elective intimate filler procedure with limited high-quality evidence and variable patient-reported outcomes.
If the main concern is pain, dryness, low libido, trauma, infection symptoms or pelvic-floor dysfunction, another assessment pathway may be more appropriate first.
Patient safety
Why proper assessment matters
Exclusion criteria make the page more trustworthy. They show that the clinic is not treating every intimate concern as a sales opportunity.
It clarifies the goal
The clinician should identify whether the concern is local sensation, pain, dryness, libido, orgasm difficulty, confidence or a mixture of factors.
It protects safety
Active infection, unexplained bleeding, pregnancy, breastfeeding, severe pain or urinary difficulty should be assessed before treatment.
It separates treatments
G-Shot, O-Shot, PRP and intimate filler are often discussed together online, but they are not interchangeable.
It sets expectations
Any potential benefit is temporary and individual. Non-response should lead to review rather than automatic repeat treatment.
A careful decision is more useful than a quick label
The strongest consultation explains the treatment aim, the uncertainty, the side effects, the alternatives and the plan if symptoms do not improve.
That approach is especially important for intimate symptoms, where anatomy, comfort, hormones, arousal, pain and confidence can overlap.
Considerations
What to consider before booking
Patients should be asked about infections, bleeding, urinary symptoms, pelvic pain, allergies, fillers, immune or healing problems, pregnancy, breastfeeding, medication and previous pelvic procedures.
Consultation priorities
Preoperative Consultation:: Patients undergo a medical and psychological assessment to discuss motivations, assess anatomical suitability, and rule out unrealistic expectations.
Consent
Aftercare
Follow-up
Before treatment
A consultation should screen for infection, unexplained bleeding, pregnancy, breastfeeding, pelvic pain, urinary symptoms and expectations.
During the procedure
Depending on protocol, care may include positioning, cleansing, topical or local anaesthetic, careful filler placement and immediate aftercare advice.
Aftercare
Patients should receive written guidance on pelvic rest, sex, tampons, hygiene, activity and symptoms that need medical advice.
When to reassess
Persistent pain, urinary symptoms, filler concerns, dissatisfaction or lack of benefit should lead to review before any further treatment.
Practical expectations
Procedure Duration:: The entire process is rapid, typically taking less than 30 minutes.
Pricing and treatment plans should be confirmed with the clinic or current pricing page before booking; they should not be guessed from competitor pages.
Common concerns and myths
Common misunderstandings
G-Shot content online can be promotional, so the final page should correct simple claims with balanced clinical context.
Myth: non-surgical means suitable for everyone
Reality: Non-surgical procedures can still be unsuitable or risky.
Myth: infection can be ignored
Reality: Active infection should be treated before elective injection.
Myth: contraindications are just paperwork
Reality: They are part of safe consent and help avoid preventable harm.
Evidence and uncertainty
Professional commentary on female genital cosmetic procedures supports cautious claims, explicit consent and honest discussion of limited evidence.
Alternatives and combined care
Depending on the concern, alternatives may include pelvic-health assessment, menopause care, psychosexual support, pain assessment or choosing no procedure.
Safety checklist
Safety checklist
Use these questions to decide whether the next step should be consultation, further assessment, treatment planning or medical review.
Has the concern been defined?
Be clear whether the issue is sensation, orgasm, libido, pain, dryness, confidence, anatomy or something else.
Are red flags absent?
Active infection, unexplained bleeding, pregnancy, breastfeeding, severe pain or urinary difficulty should be assessed before treatment.
Are options clear?
Ask how G-Shot differs from O-Shot, PRP, labial filler, pelvic-floor care and medical treatment for symptoms.
Is follow-up planned?
You should know what to expect, what aftercare to follow, when to seek help and how response will be reviewed.
Reassuring signs
It is more reasonable to discuss treatment when goals are clear, red flags are absent, expectations are realistic and aftercare is understood.
Realistic goals
Aftercare clear
Reasons to pause
Active infection, unexplained bleeding, pregnancy, breastfeeding, severe pain or urinary difficulty should be assessed before treatment.
Infection signs
Urinary change
When to escalate
When to seek medical help
Some symptoms should be assessed promptly before or after any elective intimate treatment. Use NHS 111 online
Severe or worsening pain
Seek medical advice if pelvic, vulval or vaginal pain is severe, sudden, worsening or unexplained.
Bleeding or discharge
Unexplained bleeding, heavy bleeding, bleeding after sex, foul-smelling discharge or unusual discharge should be reviewed.
Infection or urinary symptoms
Fever, feeling unwell, worsening swelling, offensive discharge, burning urine or difficulty passing urine needs prompt advice.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or severe sudden illness.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
Regulatory resources
Authoritative resources
These resources support cautious, evidence-aware discussion of G-Shot, G-spot amplification and female genital cosmetic procedures.
DermNet: female genital cosmetic surgery
DermNet summarises female genital cosmetic surgery, including professional caution around G-spot amplification until stronger evidence is available.
RACGP female genital cosmetic surgery toolkit
This professional toolkit explains that commercial terms such as G-Shot can create confusion and that evidence and risks should be discussed clearly.
ASPS overview of O and G shots
ASPS gives a concise professional distinction between PRP-based O-Shot terminology and filler-based G-Shot terminology.
Next step
Book a clinical consultation
A consultation can confirm whether the G-Shot is worth discussing, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 87 imported records. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. G-Shot treatment is an elective, off-label intimate filler procedure in this context, and suitability must be confirmed after individual consultation. Results vary. Not a cure.
